Clearwater Paper (CLW) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
18 Feb, 2026Executive summary
Net sales reached $1.6 billion in 2025, up 12% year-over-year, driven by a 14% increase in shipments, primarily from the Augusta Mill integration and full-year operation.
Adjusted EBITDA improved by $71 million to $107 million, reflecting strong cost control, execution, and over $50 million in fixed cost reductions, including $16 million in SG&A savings.
Net loss from continuing operations was $53 million, or $3.28 per diluted share, mainly due to a non-cash goodwill impairment, partially offset by insurance proceeds.
Share repurchases totaled $17 million, with $79 million remaining authorized; liquidity exceeded $400 million at year-end.
Integration of the Augusta Mill and separation of the tissue business were completed ahead of schedule and below targeted costs.
Financial highlights
Q4 2025 net sales were $386 million, flat year-over-year, with net income from continuing operations at $3 million, including $17 million in insurance proceeds.
Full-year net loss from continuing operations was $53 million, primarily due to a non-cash goodwill impairment.
Adjusted EBITDA for Q4 2025 was $20 million, above guidance midpoint, aided by cost reductions and insurance proceeds.
Sales volumes for 2025 were 1,236,114 tons, up 14% year-over-year; average net selling price decreased 4% to $1,167 per ton.
Net leverage ratio at year-end was 2.5x, with available liquidity of $439 million.
Outlook and guidance
Q1 2026 adjusted EBITDA expected to be approximately break even due to operational disruptions and higher costs from severe weather, resulting in $15-$20 million incremental costs.
2026 revenue guidance is $1.4-$1.5 billion, with flat to modest shipment growth and a $70 million pricing headwind from 2025 carryover.
Capital expenditures projected at $65-$75 million; $20 million working capital improvement expected, weighted to the back half of the year.
Assumptions exclude impact from recent price increases and RISI's latest forecast; net productivity expected to offset 2%-3% input cost inflation.
Management expects industry oversupply and low operating rates to pressure margins but anticipates medium-term recovery driven by demand growth, lower imports, and supply changes.
Latest events from Clearwater Paper
- Major transformation, cost savings, and ESG progress drive 2026 proxy proposals and governance.CLW
Proxy Filing5 Mar 2026 - Q2 net sales up 12% but net loss; tissue sale to reduce debt and boost paperboard focus.CLW
Q2 20242 Feb 2026 - Augusta mill acquisition boosts scale and reach as high utilization supports strong margins.CLW
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Augusta acquisition and tissue sale drove higher sales, debt reduction, and a paperboard focus.CLW
Q4 202422 Jan 2026 - Q3 sales and volumes rose, but margins fell; $100M buyback and debt reduction followed tissue sale.CLW
Q3 202416 Jan 2026 - Q1 net sales up 46% to $378M, with cost savings and Augusta synergies driving EBITDA growth.CLW
Q1 202523 Dec 2025 - Major strategic shifts, robust governance, and strong ESG focus define this proxy cycle.CLW
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and stock plan amendment.CLW
Proxy Filing1 Dec 2025 - Q2 net sales up 14% to $392M; Adjusted EBITDA $40M; cost cuts offset industry headwinds.CLW
Q2 202516 Nov 2025